Analyst Ratings For AzurRx BioPharma (NASDAQ:AZRX)
Today, HC Wainwright reiterated its Buy rating on AzurRx BioPharma (NASDAQ:AZRX) with a price target of $8.00.
Some recent analyst ratings include
- 1/19/2018-HC Wainwright Reiterated Rating of Buy.
- 12/6/2016-WallachBeth Capital initiated coverage with a Buy rating.
Recent Insider Trading Activity For AzurRx BioPharma (NASDAQ:AZRX)
AzurRx BioPharma (NASDAQ:AZRX) has insider ownership of 9.10% and institutional ownership of 8.18%.
- On 6/30/2017 Pelican Partners Llc, Major Shareholder, sold 160,000 with an average share price of $3.19 per share and the total transaction amounting to $510,400.00.
Recent Trading Activity for AzurRx BioPharma (NASDAQ:AZRX)
Shares of AzurRx BioPharma closed the previous trading session at 3.41 +0.00 0.00% with 15 shares trading hands.